GlaxoSmithKline PLC ADR (GSK) — Financial Flexibility Index
GlaxoSmithKline PLC ADR (GSK) has a Financial Flexibility Index of 0.03x as of March 2026. Free cash flow of $1.58 Billion (operating CF $1.14 Billion minus capex $443.00 Million) represents 0% of total liabilities ($59.93 Billion). Check GlaxoSmithKline PLC ADR PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
GlaxoSmithKline PLC ADR Financial Flexibility Index (1990–2025)
Historical Financial Flexibility Index trend for GlaxoSmithKline PLC ADR across 36 annual periods. See GlaxoSmithKline PLC ADR short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for GlaxoSmithKline PLC ADR (1990–2025)
Year-by-year free cash flow to debt coverage for GlaxoSmithKline PLC ADR. For the full company profile including market capitalisation, see GlaxoSmithKline PLC ADR market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.19x | $8.46 Billion | $7.14 Billion | $45.02 Billion | ▼ -8.6% |
| 2024 | 0.21x | $9.54 Billion | $6.55 Billion | $46.38 Billion | ▲ +27.2% |
| 2023 | 0.16x | $9.52 Billion | $7.89 Billion | $58.91 Billion | ▼ -16.2% |
| 2022 | 0.19x | $9.66 Billion | $7.40 Billion | $50.05 Billion | ▲ +38.8% |
| 2021 | 0.14x | $10.88 Billion | $7.95 Billion | $78.23 Billion | ▲ +6.2% |
| 2020 | 0.13x | $10.68 Billion | $8.44 Billion | $81.50 Billion | ▲ +4.6% |
| 2019 | 0.13x | $10.18 Billion | $8.02 Billion | $81.25 Billion | ▼ -33.3% |
| 2018 | 0.19x | $10.22 Billion | $8.42 Billion | $54.39 Billion | ▲ +8.9% |
| 2017 | 0.17x | $9.12 Billion | $6.92 Billion | $52.89 Billion | ▲ +5.5% |
| 2016 | 0.16x | $8.85 Billion | $6.50 Billion | $54.12 Billion | ▲ +63.0% |
| 2015 | 0.10x | $4.47 Billion | $2.57 Billion | $44.57 Billion | ▼ -48.3% |
| 2014 | 0.19x | $6.93 Billion | $5.18 Billion | $35.72 Billion | ▼ -25.5% |
| 2013 | 0.26x | $8.92 Billion | $7.22 Billion | $34.27 Billion | ▲ +53.4% |
| 2012 | 0.17x | $5.89 Billion | $4.38 Billion | $34.73 Billion | ▼ -27.8% |
| 2011 | 0.23x | $7.58 Billion | $6.25 Billion | $32.25 Billion | ▼ -10.0% |
| 2010 | 0.26x | $8.43 Billion | $6.80 Billion | $32.31 Billion | ▼ -13.7% |
| 2009 | 0.30x | $9.71 Billion | $7.84 Billion | $32.12 Billion | ▲ +0.2% |
| 2008 | 0.30x | $9.38 Billion | $7.31 Billion | $31.07 Billion | ▼ -19.8% |
| 2007 | 0.38x | $7.94 Billion | $5.79 Billion | $21.09 Billion | ▲ +7.9% |
| 2006 | 0.35x | $5.55 Billion | $3.96 Billion | $15.90 Billion | ▲ +1.2% |
| 2005 | 0.34x | $6.77 Billion | $5.59 Billion | $19.63 Billion | ▲ +16.8% |
| 2004 | 0.30x | $5.02 Billion | $4.77 Billion | $17.01 Billion | ▼ -22.7% |
| 2003 | 0.38x | $5.91 Billion | $4.85 Billion | $15.49 Billion | ▲ +33.0% |
| 2002 | 0.29x | $4.29 Billion | $3.06 Billion | $14.94 Billion | ▼ -32.0% |
| 2001 | 0.42x | $5.73 Billion | $4.61 Billion | $13.57 Billion | ▲ +80.5% |
| 2000 | 0.23x | $2.96 Billion | $1.85 Billion | $12.63 Billion | ▲ +52.8% |
| 1999 | 0.15x | $1.11 Billion | $510.00 Million | $7.23 Billion | ▲ +13.7% |
| 1998 | 0.13x | $885.00 Million | $410.00 Million | $6.58 Billion | ▼ -14.5% |
| 1997 | 0.16x | $1.03 Billion | $615.00 Million | $6.55 Billion | ▼ -11.3% |
| 1996 | 0.18x | $1.25 Billion | $849.00 Million | $7.05 Billion | ▼ -23.8% |
| 1995 | 0.23x | $1.94 Billion | $1.25 Billion | $8.32 Billion | ▼ -40.3% |
| 1994 | 0.39x | $2.93 Billion | $2.45 Billion | $7.53 Billion | ▼ -34.4% |
| 1993 | 0.59x | $1.63 Billion | $1.05 Billion | $2.74 Billion | ▲ +8.5% |
| 1992 | 0.55x | $1.53 Billion | $927.00 Million | $2.80 Billion | ▼ -10.5% |
| 1991 | 0.61x | $1.25 Billion | $657.00 Million | $2.04 Billion | ▲ +23.5% |
| 1990 | 0.50x | $1.22 Billion | $615.00 Million | $2.46 Billion | — |